Skip to main content
. 2019 Jul 10;21(8):1159–1166. doi: 10.1093/europace/euz175

Figure 1.

Figure 1

Study selection diagram for trials comparing vernakalant to placebo or active drug in patients with recent-onset atrial fibrillation.